Envoy Medical Inc COCH
๐ Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-03-02 |
| Shares Out. | 76,880,000 |
| Website | envoymedical.com/ โ |
| Phone | 16513618000 |
| Employees | 47 |
| Revenue | $39,000 |
| Gross Profit | -$274,000 |
| Net Income | -$4.4M |
| Free Cash Flow | -$20.7M |
| Total Assets | $29.8M |
| Total Liabilities | $19.3M |
| Equity | $10.2M |
About Envoy Medical Inc
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Envoy Medical Inc is a publicly traded company under the ticker symbol COCH on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
7 analysts (2026-07-01)

